Eli Lilly announced it will add another $1.6 billion and 200 jobs to its Boone County project. This is the largest investment in a single site in Lilly’s history, according to a company news release. (Indianapolis Star)
Life-sciences company Danaher has stopped pursuing Catalent. People familiar with the matter said Danaher is no longer interested in buying the contract manufacturer. (Bloomberg)
Argentina has sterilized mosquitoes with atomic radiation as it battles a major dengue outbreak. The South American country has this year recorded over 41,000 cases of the disease transmitted by mosquitoes, far above the equivalent level in previous years of major outbreaks in 2020 and 2016, government data showed. (Reuters)
Johnson & Johnson’s Janssen tapped into Pipeline Therapeutics’ neuroscience asset for $50 million upfront. The San Diego biotech tested its investigational compound, the muscarinic M1 antagonist PIPE-307, in two Phase I studies and has gained an FDA go-ahead for a mid-stage study in patients with relapsing-remitting multiple sclerosis, or RRMS. (Endpoints News)
Agenus won a Fast-Track Designation from the Food and Drug Administration for its combination colon cancer treatment of Botensilimab and Balstilimab. The company’s stock rose sharply on the news Monday. (Seeking Alpha)
